Iloprost Teva

Iloprost, the active ingredient in Iloprost Teva, is a prostacyclin analog presented as a unknown/unknown for intravenous use. It treats pulmonary arterial hypertension and digital ulcers associated with systemic sclerosis. GNH USA supplies Iloprost Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iloprost acts on the prostacyclin pathway to provide vasodilation and antiplatelet effects in specific vascular conditions.

Pulmonary arterial hypertension: improves exercise capacity and hemodynamic parameters. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces the formation of new ulcers.

Iloprost may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Flushing - Headache - Nausea - Jaw pain

Serious or Rare Side Effects: - Severe hypotension - Pulmonary edema - Bleeding complications

Before initiating Iloprost therapy, clinicians should consider several safety measures.

Monitor blood pressure: watch for hypotensive episodes during infusion. Assess bleeding risk: avoid concurrent use with strong anticoagulants unless necessary. Use cautiously after recent myocardial infarction: risk of further cardiac ischemia. Adjust dose in renal or hepatic impairment: impaired clearance may increase exposure. Avoid in uncontrolled infection: systemic vasodilation may worsen sepsis. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iloprost can interact with other medicines that affect vascular tone or coagulation.

Major Interactions (Avoid): - Potent vasodilators (e.g., nitroglycerin): additive hypotension. - Anticoagulants (e.g., warfarin): increased bleeding risk. - Endothelin receptor antagonists: potential for excessive blood‑pressure drop.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance vasodilatory effect. - Phosphodiesterase inhibitors: possible synergistic hypotension. - Non‑steroidal anti‑inflammatory drugs: may affect platelet function.